ERYTECH Provides Business Update and Reports Financial Highlights for Third Quarter 2016 Post author:admERY Post published:November 3, 2016 Post category:Newsroom ERYTECH today provided a business update and reported its financial results for the quarter ended September 30, 2016. You Might Also Like ERYTECH Presents New Preclinical Anti-Tumor Data on erymethionase at AACR 2017 March 20, 2017 ERYTECH Requested a Pre-BLA Meeting with the FDA to Discuss Path to Approval in ALL April 20, 2021 ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States May 13, 2019
ERYTECH Announces FDA’s Authorization to Proceed with Phase 3 Trial for Eryaspase in Pancreatic Cancer in the United States May 13, 2019
